CERIOND Trademark

Trademark Overview


On Friday, April 13, 2012, a trademark application was filed for CERIOND with the United States Patent and Trademark Office. The USPTO has given the CERIOND trademark a serial number of 85597323. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 18, 2013. This trademark is owned by Eli Lilly and Company. The CERIOND trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants
ceriond

General Information


Serial Number85597323
Word MarkCERIOND
Filing DateFriday, April 13, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 18, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 20, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, November 18, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 18, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 2, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 30, 2013EXTENSION 1 GRANTED
Wednesday, March 13, 2013EXTENSION 1 FILED
Friday, March 29, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 13, 2013TEAS EXTENSION RECEIVED
Tuesday, October 16, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 12, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 11, 2012ASSIGNED TO EXAMINER
Friday, April 20, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 17, 2012NEW APPLICATION ENTERED IN TRAM